94 related articles for article (PubMed ID: 1626954)
21. [The clinical information value of an immunoenzyme study of the tumor markers CA-19-9, CEA and AFP in cancer of the stomach, pancreas, colon and rectum].
Ial'chenko NA; Lagutin VD; Lavik NN; Musin II
Vopr Onkol; 1991; 37(9-10):921-4. PubMed ID: 1726842
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic prognostic factors in patients with Borrmann type 4 gastric cancer: univariate and multivariate analyses.
Yokota T; Kunii Y; Saito T; Teshima S; Narushima Y; Yamada Y; Iwamoto K; Kagami M; Takahashi M; Kikuchi S; Yamauchi H
Ups J Med Sci; 2000; 105(3):227-34. PubMed ID: 11261608
[TBL] [Abstract][Full Text] [Related]
23. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
Guadagni F; Roselli M; Amato T; Cosimelli M; Perri P; Casale V; Carlini M; Santoro E; Cavaliere R; Greiner JW
Cancer Res; 1992 Mar; 52(5):1222-7. PubMed ID: 1737383
[TBL] [Abstract][Full Text] [Related]
24. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804
[TBL] [Abstract][Full Text] [Related]
25. [Initial experiences with CA-15-3 determination in the serum of patients with breast cancer].
Bartel U; Johannsen B; Reiss H; Elling D
Zentralbl Gynakol; 1989; 111(21):1417-24. PubMed ID: 2557715
[TBL] [Abstract][Full Text] [Related]
26. Serum levels of CA 50 in nonmalignant liver diseases: a clinical and biochemical study.
Collazos J; Genolla J; Ruibal A
Am J Gastroenterol; 1993 Mar; 88(3):409-12. PubMed ID: 8438849
[TBL] [Abstract][Full Text] [Related]
27. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Haglund C
Anticancer Res; 2002; 22(4):2311-6. PubMed ID: 12174919
[TBL] [Abstract][Full Text] [Related]
28. Clinical evaluation of tumor-associated mucin-type glycoprotein CA 54/61 in ovarian cancers: comparison with CA 125.
Suzuki M; Sekiguchi I; Tamada T
Obstet Gynecol; 1990 Sep; 76(3 Pt 1):422-7. PubMed ID: 2381620
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer.
Spila A; Ferroni P; Cosimelli M; D'Alessandro R; Carone MD; Aloe S; Tedesco M; Mancini R; Casale V; Carlini S; Casciani CU; Roselli M; Guadagni F
Anticancer Res; 1999; 19(2B):1363-8. PubMed ID: 10365107
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.
Ucar E; Semerci E; Ustun H; Yetim T; Huzmeli C; Gullu M
Adv Ther; 2008 Oct; 25(10):1075-84. PubMed ID: 18821070
[TBL] [Abstract][Full Text] [Related]
31. [Utility of dopa decarboxylase as a novel marker for the detection of peritoneal micro-metastases of gastric cancer with realtime RT-PCR].
Sakakura C; Takemura M; Miyagawa K; Fukuda K; Shimomura K; Kin S; Nakase Y; Kuriu Y; Nakashima S; Yoshikawa T; Ueda Y; Fujiyama J; Sonoyama T; Okazaki Y; Hayashizaki Y; Hagiwara A; Yamagishi H
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1906-8. PubMed ID: 15553755
[TBL] [Abstract][Full Text] [Related]
32. A comparison of the clinical usefulness of CA 19-9 and CA 50 in the diagnosis and monitoring of gastrointestinal cancers.
Kokociñska D; Jarzab B; Król R; Ziaja K; Szejbak K; Kuśmierski S
J Environ Pathol Toxicol Oncol; 1996; 15(2-4):283-7. PubMed ID: 9216823
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of T antigen expression in patients with gastric carcinoma.
Chung YS; Yamashita Y; Kato Y; Nakata B; Sawada T; Sowa M
Cancer; 1996 May; 77(9):1768-73. PubMed ID: 8646672
[TBL] [Abstract][Full Text] [Related]
34. [The CA-125 tumor marker in epithelial ovarian cancers of stage I].
Nagele F; Vavra N; Kurz C; Sevelda P
Wien Klin Wochenschr; 1993; 105(20):585-8. PubMed ID: 8259686
[TBL] [Abstract][Full Text] [Related]
35. [Histological localization of TAG72 in gastric cancers and a clinico-pathological study of the CA72-4 serum values].
Konishi F; Matzunou H; Konishi K; Yamamichi N
Gan No Rinsho; 1990 May; 36(6):691-9. PubMed ID: 2161468
[TBL] [Abstract][Full Text] [Related]
36. Serum CA-15.3 and CEA patterns in postsurgical follow-up, and in monitoring clinical course of metastatic cancer in patients with breast carcinoma.
al-Jarallah MA; Behbehani AE; el-Nass SA; Temim L; Ebraheem AK; Ali MA; Szymendera JJ
Eur J Surg Oncol; 1993 Feb; 19(1):74-9. PubMed ID: 8436243
[TBL] [Abstract][Full Text] [Related]
37. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases.
Mimori K; Fukagawa T; Kosaka Y; Ishikawa K; Iwatsuki M; Yokobori T; Hirasaki S; Takatsuno Y; Sakashita H; Ishii H; Sasako M; Mori M
Ann Surg Oncol; 2008 Oct; 15(10):2934-42. PubMed ID: 18661187
[TBL] [Abstract][Full Text] [Related]
38. Serum CA 19-9, SLX, STN and CEA levels of the peripheral and the draining venous blood in gastric cancer.
Imada T; Rino Y; Takahashi M; Hatori S; Shiozawa M; Amano T; Kondo J
Hepatogastroenterology; 1999; 46(27):2086-90. PubMed ID: 10430402
[TBL] [Abstract][Full Text] [Related]
39. Serum interleukin-12 levels in patients with gastric cancer.
Murakami S; Okubo K; Tsuji Y; Sakata H; Hamada S; Hirayama R
Surg Today; 2004; 34(12):1014-9. PubMed ID: 15580384
[TBL] [Abstract][Full Text] [Related]
40. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]